RESEARCH

NANEXA: Financing secured into 2026 to drive NEX-22 development

Analys, Research

Johan Widmark | 2025-01-27 08:00  READ FULL REPORT HERE IN PDF With the directed issue of units...

Read More

GRANGEX: PEA confirmns robust economics for Sydvaranger – mapping the road to financial close in H2’25

Analys, Research

With the release of a Preliminary Economic Assessment (PEA) for the restart of the Sydvaranger...

Read More

PROLIGHT: SpinChip deal highlights the strategic importance and valuation potential of Prolight’s solution

Analys, Research

The recent acquisition of Norwegian point-of-care diagnostics platform SpinChip by bioMérieux for...

Read More

PROLIGHT: Commercial prototype marks an important milestone towards upcoming studies

Analys, Research

The arrival of the first commercial prototype instruments for Prolight’s Psyros Point of Care...

Read More

PROLIGHT: Advancing with strengthened financials towards clinical performance study in 2025

Analys, Research

Prolight continues to make progress with its proprietary Psyros platform, with a pre-validation...

Read More

NANEXA: Progress for rival at Novo illustrates the significant value potential in Nanexa

Analys, Research

NEX-22 is progressing as expected, with the last patient in Phase I treated, results anticipated...

Read More

CRUNCHFISH: Q3 report webinar

Analys, Research

On Friday Nov 1st, 2024 Crunchfish hosted a webinar in connection with the Q3’24 report,...

Read More

TALLINK: All about the Dividend

Okategoriserade, Research

RESEARCH COLLABORATION WITH ENLIGHT RESEARCH  Q3 Sales and Profits beat estimates, but the...

Read More